Replimune Group, Inc. — Director's Dealing 2018

Jul 20, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2018-07-19

Reporting Person: Esposito Pamela (Chief Business Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$1.01	2025-11-01	Common Stock (149203)		Direct
Employee Stock Option (Right to Buy)	$1.75	2026-03-01	Common Stock (196162)		Direct
Employee Stock Option (Right to Buy)	$3.30	2027-07-26	Common Stock (134281)		Direct

Footnotes

F1: All of the shares underlying this stock option have vested other than 12,433 shares which vest on September 30, 2018.

F2: 102,168 shares underlying this stock option have vested and the remainder of the shares underlying this stock option vest in 20 equal monthly installments as of the 29th of each month.

F3: 25% of the shares underlying this stock option vest on July 26, 2018 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter.